Literature DB >> 20675517

Using apolipoprotein B to manage dyslipidemia.

Jennifer G Robinson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20675517      PMCID： PMC2912744          DOI： 10.4065/mcp.2010.0287

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN： 0025-6196            Impact factor:   7.616


× No keyword cloud information.
  5 in total

1.  Using apolipoprotein B to manage dyslipidemic patients: time for a change?

Authors:  Charles R Harper; Terry A Jacobson
Journal:  Mayo Clin Proc       Date:  2010-05       Impact factor: 7.616

2.  To B or not to B: is non-high-density lipoprotein cholesterol an adequate surrogate for apolipoprotein B?

Authors:  Carl J Lavie; Richard V Milani; James H O'Keefe
Journal:  Mayo Clin Proc       Date:  2010-05       Impact factor: 7.616

3.  PREVENTION OF ATHEROSCLEROSIS WITH LDL-C LOWERING - LIPOPROTEIN CHANGES AND INTERACTIONS: THE SANDS STUDY.

Authors:  Wm James Howard; Marie Russell; Jerome L Fleg; Mihriye Mete; Tauqeer Ali; Richard B Devereux; James M Galloway; James D Otvos; Robert E Ratner; Mary J Roman; Angela Silverman; Jason G Umans; Neil J Weissman; Charlton Wilson; Barbara V Howard
Journal:  J Clin Lipidol       Date:  2009-10-01       Impact factor: 4.766

4.  Major lipids, apolipoproteins, and risk of vascular disease.

Authors:  Emanuele Di Angelantonio; Nadeem Sarwar; Philip Perry; Stephen Kaptoge; Kausik K Ray; Alexander Thompson; Angela M Wood; Sarah Lewington; Naveed Sattar; Chris J Packard; Rory Collins; Simon G Thompson; John Danesh
Journal:  JAMA       Date:  2009-11-11       Impact factor: 56.272

5.  Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment.

Authors:  John J P Kastelein; Wim A van der Steeg; Ingar Holme; Michael Gaffney; Nilo B Cater; Philip Barter; Prakash Deedwania; Anders G Olsson; S Matthijs Boekholdt; David A Demicco; Michael Szarek; John C LaRosa; Terje R Pedersen; Scott M Grundy
Journal:  Circulation       Date:  2008-06-02       Impact factor: 29.690
  5 in total
  1 in total

Review 1.  Opening a new lipid "apo-thecary": incorporating apolipoproteins as potential risk factors and treatment targets to reduce cardiovascular risk.

Authors:  Terry A Jacobson
Journal:  Mayo Clin Proc       Date:  2011-08       Impact factor: 7.616
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.